Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05546580
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2022-09-15
Brief Title:
Study of Iadademstat and Gilteritinib in Patients With RR AML With FMS-like Tyrosine Kinase Mutation FLT3 Mut
Sponsor:
Oryzon Genomics SA
Organization:
Oryzon Genomics SA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-15
First Submit QC Date:
September 15 2022
Study First Post Date:
2022-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-26
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED